Do IgG Level Variations in CIDP and MMN Patients Following Initial Intravenous IVIg Treatment Correlate With Ultimate Dosing (digG)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT04356781

Recruitment Status : Not yet recruiting

First Posted : April 22, 2020

Last Update Posted : May 5, 2020

See Contacts and Locations

Sponsor:

Collaborator:

Instituto Grifols, S.A.

Information provided by (Responsible Party):

Walton Centre NHS Foundation Trust

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Not yet recruiting
Estimated Primary Completion Date :	June 30, 2022
Estimated Study Completion Date :	June 30, 2023

To Top